| September 03, 2010 |
FMI Holdings Ltd. (formerly Forbes Medi-Tech Inc.) Announces Appointment of Abakhan & Associates Inc. as Liquidators |
| August 27, 2010 |
Forbes Medi-Tech Announces Closing of Asset Sale to Pharmachem Laboratories, Inc.and Change of Name to FMI Holdings Ltd. |
| August 20, 2010 |
Forbes Medi-Tech Announces Acceptance of Revised Offer from Pharmachem Laboratories, Inc. and Intention to Reconvene Annual and Special Meeting |
| August 16, 2010 |
Forbes Medi-Tech Provides Further Update on Revised Offer from Pharmachem Laboratories, Inc. and Announces Intention to Adjourn Portion of Annual and Special Meeting |
| August 13, 2010 |
Forbes Medi-Tech Announces Financial Results For Second Quarter Ended June 30, 2010 |
| August 09, 2010 |
Forbes Medi-Tech provides update on Revised Offer from Pharmachem Laboratories, Inc. |
| August 06, 2010 |
Forbes Medi-Tech Receives Revised Offer from Pharmachem Laboratories, Inc. |
| August 05, 2010 |
Forbes Medi-Tech enters into Amended Agreement with MHT, LLC |
| July 29, 2010 |
Forbes Medi-Tech receives Formal Offer from Pharmachem Laboratories, Inc. |
| July 20, 2010 |
Forbes Medi-Tech Receives Proposal from Pharmachem Laboratories, Inc. |
| July 13, 2010 |
Forbes Medi-Tech Announces the Sale of its Reducol(tm) Business to MHT, LLC an Affiliate of Marco Hi-Tech JV LLC |
| May 10, 2010 |
Forbes Medi-Tech Announces Financial Results For First Quarter Ended March 31, 2010 |
| April 09, 2010 |
Forbes Medi-Tech Announces Listing on the Over-the-Counter Bulletin Board |
| March 31, 2010 |
Forbes Medi-Tech Announces Financial Results for the Year ended December 31, 2009 |
| February 17, 2010 |
Forbes Medi-Tech Announces Receipt of NASDAQ Panel Decision to Delist Common Stock |
| January 14, 2010 |
Forbes Medi-Tech Appeals NASDAQ Listing Suspension |
| January 08, 2010 |
Forbes Medi-Tech Provides Update on NASDAQ Listing |
| December 07, 2009 |
Forbes Medi-Tech Announces the launch of Del Monte Heart Smart Pineapple Juice containing Reducol(tm) in the Philippines |
| November 09, 2009 |
Forbes Medi-Tech Announces Financial Results For Third Quarter Ended September 30, 2009 |
| October 26, 2009 |
Forbes Medi-Tech cholesterol lowering ingredient Reducol(tm) receives new health claim in the European Union |
| August 13, 2009 |
Forbes Medi-Tech Announces Financial Results for Second Quarter Ended June 30, 2009 |
| August 12, 2009 |
Forbes Medi-Tech Provides Update on TSX Listing |
| July 15, 2009 |
Forbes Medi-Tech Provides Update on Stock Exchange Listings |
| June 10, 2009 |
Forbes Medi-Tech Announces Pharmavite Contract Renewal |
| May 15, 2009 |
Forbes Medi-Tech Regains Compliance with "Stockholders' Equity" Listing Requirement on Nasdaq Capital Market |
| May 12, 2009 |
Forbes Medi-Tech Announces Financial Results for First Quarter Ended March 31, 2009 |
| April 29, 2009 |
Forbes Medi-Tech Receives Final Proceeds from Non-Dilutive Funding Transaction |
| April 15, 2009 |
Forbes Medi-Tech Provides Update on NASDAQ Listing |
| April 08, 2009 |
Forbes Medi-Tech Comments on Recent Stock Activity |
| March 30, 2009 |
Forbes Medi-Tech Announces Financial Results for the Year ended December 31, 2008 |
| February 10, 2009 |
Forbes Medi-Tech Provides Update on Additional Funding from Non-Dilutive Funding Transaction |
| February 09, 2009 |
Leading Healthy Lifestyle Magazine Highlights Clinically Proven Benefits of Forbes Medi-Tech's Cholesterol-Lowering Ingredient, Reducol(TM) |
| January 14, 2009 |
Forbes Medi-Tech Provides Update on TSX Listing ~Company Receives Notice of TSX Delisting Review~ |
| January 05, 2009 |
Forbes Medi-Tech Receives Extension to Compliance Deadline ~NASDAQ Extends Its Suspension of the Bid Price Requirement~ |
| November 13, 2008 |
Forbes Medi-Tech Announces Third Quarter 2008 Financial Results |
| October 22, 2008 |
Forbes Medi-Tech Receives Extension to Compliance Deadline ~NASDAQ Temporarily Suspends Enforcement of the Bid Price Requirement~ |
| October 09, 2008 |
Forbes Medi-Tech Showcases Frozen Fudge Bar Containing Its Cholesterol-Lowering Reducol(tm) Ingredient at the 2008 National Frozen & Refrigerated Foods Convention |
| September 19, 2008 |
Forbes Medi-Tech Provides Update on Nasdaq Listing Status |
| September 18, 2008 |
Forbes Medi-Tech Announces Reducol(tm) Expansion in South America with New Yogurt Drink Launched in Uruguay |
| August 21, 2008 |
Forbes Medi-Tech Continues European Expansion with Product Launch in Finland ~Reducol(TM) Product Line Expanded with the Introduction of Processed Cheese Slices~ |
| August 18, 2008 |
Forbes Medi-Tech Announces Sale of Pharmaceutical Assets ~Company Focuses on Building Its Revenue-Generating Nutraceutical Business~ |
| August 12, 2008 |
Forbes Medi-Tech Announces Second Quarter 2008 Financial Results |
| June 17, 2008 |
Forbes Medi-Tech Achieves "Minimum Bid Price Requirement" for Continued Listing on The Nasdaq Stock Market |
| June 09, 2008 |
Forbes Medi-Tech Receives Extension to Achieve Nasdaq's "Minimum Bid Price Requirement" |
| May 22, 2008 |
Forbes Medi-Tech Restructures Board by Reducing Number of Directors from Six to Four ~Greg Anderson Appointed as Director and Joe Dunne Named as Chair~ |
| May 15, 2008 |
Forbes Medi-Tech Announces Corporate Restructuring --Company To Focus Exclusively on Core Nutraceutical Business and Reduce 2008 Research and Development Expenses by Approximately $2.7 Million-- |
| May 14, 2008 |
Forbes Medi-Tech Announces First Quarter 2008 Financial Results |
| May 12, 2008 |
Forbes Medi-Tech Announces Completion of $3.8 Million Non-Dilutive Funding Transaction |
| April 24, 2008 |
Forbes Medi-Tech Announces Pharmavite Contract Renewal ~Following Strong Volume Growth in 2007, the Company Looks to Further Expand Product Line with Reducol(tm)-Based Products~ |
| April 01, 2008 |
Forbes Medi-Tech now Trading under former NASDAQ Trading Symbol 'FMTI' |
| March 31, 2008 |
Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2007 |
| March 20, 2008 |
Forbes Medi-Tech Announces $3.8 Million Non-Dilutive Funding Transaction |
| March 19, 2008 |
Forbes Enters Into New Collaboration for Reducol(tm) in Germany, Austria and Switzerland |
| March 10, 2008 |
Italy's Fiave Launches Premium Brand Natural Products with Reducol(tm)~First Brand Name Product Launch in Europe~ |
| March 03, 2008 |
Forbes Medi-Tech announces Trading of Common Shares on Post-Exchange Basis |
| February 26, 2008 |
Forbes Medi-Tech Establishes Exchange Ratio for Corporate Reorganization |
| February 14, 2008 |
Forbes Medi-Tech Issues Results from Special General Meeting |
| February 07, 2008 |
Forbes Medi-Tech Forecasts Strong Revenue Growth in 2008 |
| January 31, 2008 |
ISS Recommends Forbes Medi-Tech Shareholders Vote 'FOR' the Proposed Corporate Reorganization |
| January 23, 2008 |
Forbes Medi-Tech Provides Update on Nasdaq Listing Status |
| January 14, 2008 |
Forbes Medi-Tech Files Meeting Documents For Previously Announced Plan of Arrangement |
| December 20, 2007 |
Forbes Medi-Tech Announces Plan of Arrangement |
| December 04, 2007 |
Forbes Medi-Tech Continues Reducol(tm) Expansion in France with Auchan |
| November 14, 2007 |
Forbes Medi-Tech Announces Third Quarter 2007 Financial Results |
| November 13, 2007 |
Forbes Medi-Tech Announces Timing of Third Quarter Financials and Corporate Update |
| October 30, 2007 |
Forbes Medi-Tech Enters Final Steps in Compound Selection for Asthma and Type 2 Diabetes |
| October 24, 2007 |
Forbes Medi-Tech Increases Revenue Guidance Range 16% to $8.75 to $9.25 Million |
| October 02, 2007 |
Netherlands's Largest SuperMarket Chain, Albert Heijn, Expands Range of Reducol(tm) Products |
| September 06, 2007 |
Fennobon of Finland Launches Cholesterol-Lowering Chewing Gum with Reducol(tm) |
| August 14, 2007 |
Forbes Medi-Tech Reports Financial Results for the Quarter ended June 30, 2007 |
| August 07, 2007 |
Taiwan's Largest Drink Producer Launches Reducol(tm)-Based Milk Drink |
| July 19, 2007 |
Forbes Medi-Tech on Track for Corporate Objectives Including Revenue Growth |
| July 16, 2007 |
Nasdaq Approves Forbes Medi-Tech Transfer to Nasdaq Capital Market |
| May 23, 2007 |
Reducol(tm) Product Range Expanded with Cholesterol-Lowering Rye Bread |
| May 15, 2007 |
Forbes Medi-Tech Reports Financial Results for the Quarter ended March 31, 2007 |
| May 08, 2007 |
Forbes Medi-Tech Announces Pharmavite Contract Renewal |
| March 28, 2007 |
Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2006 |
| February 12, 2007 |
Forbes Medi-Tech Announces Next Steps in Pharmaceutical Development and Corporate Restructuring |
| January 25, 2007 |
Forbes Medi-Tech Provides Update on Nasdaq Listing Status |
| January 18, 2007 |
Forbes Medi-Tech Expands Reducol(tm) Sales in Portugal with the Addition of Modelo Continente to Customer List |
| January 15, 2007 |
Forbes Medi-Tech Expands Its Line of Reducol(tm) Products with Jeronimo Martins in Portugal |
| December 13, 2006 |
Reducol(tm) Press Conference Held in France Supporting Reducol(tm) Product Launch with World's Second Largest Food Distributor, Carrefour Group |
| December 04, 2006 |
Forbes Medi-Tech Announces US Phase II Clinical Trial Results |
| November 14, 2006 |
Forbes Medi-Tech Announces Third Quarter 2006 Financial Results |
| November 02, 2006 |
Forbes Medi-Tech Announces the Expansion of Reducol(tm)-based Products at Tesco Stores Ltd |
| October 27, 2006 |
Forbes Medi-Tech Closes TheraPei Acquisition |
| October 26, 2006 |
Forbes Medi-Tech to Present at Rodman & Renshaw 8th Annual Healthcare Conference |
| October 25, 2006 |
Forbes Medi-Tech to Acquire San Diego Based TheraPei Pharmaceuticals and Appoint Dr. John Nestor as Chief Scientific Officer |
| October 17, 2006 |
Forbes Medi-Tech's Cholesterol-Lowering Drug, FM-VP4, Selected for Windhover's Top 10 List |
| October 05, 2006 |
Forbes Medi-Tech Announces the Further Expansion of Dairy Products Containing Reducol(tm) in Europe Through the Carrefour Group, Specifically Through the Champion and Carrefour Banner |
| October 02, 2006 |
Forbes Medi-Tech Announces the Completion of the US Phase II Trial for Cholesterol-Lowering Drug, FM-VP4 |
| September 05, 2006 |
Forbes Medi-Tech Announces the Expansion of Reducol(tm)-based Products at Kesko of Finland |
| August 15, 2006 |
Forbes Medi-Tech Announces Second Quarter 2006 Results |
| August 08, 2006 |
Forbes Medi-Tech Announces Progress in Pharmaceutical Development and Expansion of Reducol(tm)-Based Products at UK's Largest Retailer, Tesco Stores Ltd |
| June 22, 2006 |
Forbes Medi-Tech to Showcase Reducol(tm)-Based Products at the Institute of Food Technologists Annual Meeting and Food Expo in Orlando, Florida |
| June 19, 2006 |
Forbes Medi-Tech Strengthens Presence in Europe with Fayrefield Foods Venture |
| June 15, 2006 |
Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn |
| June 13, 2006 |
Forbes Medi-Tech Announces Completion of Enrollment for FM-VP4 US Phase II Trial |
| May 15, 2006 |
Forbes Medi-Tech announces Financial Results for the Quarter ended March 31, 2006 |
| May 09, 2006 |
Forbes Medi-Tech Announces Launch of First Cholesterol-Lowering Cheddar Cheese with Reducol(tm) at UK Wal-Mart /ASDA |
| March 31, 2006 |
Forbes Medi-Tech Announces Change in Board of Directors |
| March 30, 2006 |
Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2005 |
| March 29, 2006 |
Forbes Medi-Tech Announces Timing of Year End Financial Results |
| March 23, 2006 |
Forbes Medi-Tech Provides 2006 Outlook for Ingredient Sales, Including Reducol(tm) |
| March 14, 2006 |
Forbes Medi-Tech Announces Completion of Phyto-Source Sale and Receipt of Funds |
| February 28, 2006 |
Forbes Medi-Tech Announces Launch of Cholesterol-Lowering Milk Drink with Reducol(tm) at Tesco Stores Ltd. |
| February 23, 2006 |
Forbes Medi-Tech Agrees To Sell Sterol Manufacturing Interest for US$25 million and Signs 5 Year Supply Agreement for Reducol(tm) |
| February 13, 2006 |
Forbes Medi-Tech Announces Pharmavite Contract Renewal |
| February 10, 2006 |
Forbes Medi-Tech Inc. to Present at BIO CEO & Investor Conference |
| January 23, 2006 |
Forbes Medi-Tech Announces Extension of Major Sterol Supply Agreement |
| January 04, 2006 |
Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd |
| December 20, 2005 |
Forbes Medi-Tech Launches Cholesterol-Lowering Ingredient Reducol(tm) in the UK |
| December 02, 2005 |
Forbes Medi-Tech Initiates Dosing Phase in Clinical Trial for Cholesterol-Lowering Drug, FM-VP4 |
| November 14, 2005 |
Forbes Medi-Tech Announces Third Quarter 2005 Financial Results |
| November 11, 2005 |
Forbes Medi-Tech Announces Timing of Third Quarter Financial Results |
| November 03, 2005 |
Forbes Medi-Tech to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference |
| November 02, 2005 |
Forbes Medi-Tech Initiates US Phase II Trial for Cholesterol-Lowering Drug, FM-VP4 |
| October 27, 2005 |
Forbes Medi-Tech Completes US$6 Million Private Placement |
| October 03, 2005 |
Forbes Medi-Tech Receives FDA Clearance to Initiate US Phase II Trial for Cholesterol-Lowering Drug, FM-VP4 |
| September 28, 2005 |
Phyto-Source Manufacturing Facility Remains Intact After Hurricane Rita |
| September 15, 2005 |
Forbes Medi-Tech Preclinical Study Results Demonstrate Cholesterol-Lowering Effects of FM-VP4/Statin (Zocor(r)) Combination and Effects on Obesity~ |
| September 14, 2005 |
~Forbes Medi-Tech to Present at Merriman Curhan Ford & Co. Investor Summit~ |
| August 31, 2005 |
Forbes Medi-Tech Submits IND Application for Cholesterol-Lowering Drug, FM-VP4 |
| August 23, 2005 |
Forbes Medi-Tech Makes Valuable Addition to the Board of Directors |
| August 11, 2005 |
Forbes Medi-Tech Announces 112% Increase in Second Quarter 2005 Revenue |
| June 30, 2005 |
Forbes Medi-Tech Announces FM-VP4 Study Results to be Presented at AAPS Conference |
| June 27, 2005 |
Forbes Medi-Tech Completes FM-VP4 Toxicity Study |
| May 16, 2005 |
Forbes Medi-Tech announces Financial Results for the Quarter ended March 31, 2005 |
| May 02, 2005 |
Forbes Medi-Tech Announces Product Launch with Kesko of Finland |
| March 30, 2005 |
Forbes Medi-Tech Announces Financial Results for the 4th Quarter and Year Ended December 31, 2004 |
| March 29, 2005 |
Forbes Medi-Tech Announces Timing of Year End Financial Results and AGM |
| March 02, 2005 |
Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups |
| February 01, 2005 |
Forbes Medi-Tech Initiates Toxicity Study on FM-VP4 to Support US Phase II trial for Cholesterol-Lowering Drug |
| January 12, 2005 |
Forbes Medi-Tech Provides 2005 Revenue Guidance |
| December 01, 2004 |
Forbes Medi-Tech's Manufacturing Facility Expanded to 1500 Metric Tonnes |
| November 29, 2004 |
Forbes Medi-Tech Expands Reducol(tm) Business into Scandinavia with Scanvit Ltd, Finland |
| November 22, 2004 |
Forbes Medi-Tech Signs International Reducol (tm) Sales and Licensing Agreement |
| November 19, 2004 |
Forbes Medi-Tech Appoints Dr. Steven Nissen to Chairman of Medical & Scientific Advisory Board |
| November 15, 2004 |
Forbes Medi-Tech Announces Financial Results for the Third Quarter ended September 30, 2004 |
| November 12, 2004 |
Forbes Medi-Tech Receives Final Approval for Reducol(tm) Sales in the European Union |
| November 11, 2004 |
Forbes Medi-Tech Announces Timing of Third Quarter Financial Results |
| October 05, 2004 |
Company Appoints New Chief Financial Officer |
| October 01, 2004 |
Company Completes Regulatory Filing |
| September 08, 2004 |
Forbes Medi-Tech Announces US$24.4 Million in Sterols Sales Agreement |
| August 12, 2004 |
Forbes Medi-Tech Announces Financial Results for the Second Quarter ended June 30, 2004 |
| July 29, 2004 |
Forbes Medi-Tech Announces the Addition of Two Novel Cholesterol Absorption Inhibitors to its Drug Development Pipeline |
| July 08, 2004 |
Forbes Medi-Tech Clears Key Regulatory Hurdle for Reducol(tm) Approval in Europe |
| July 06, 2004 |
Forbes Medi-Tech Announces FM-VP4 Development Plan |
| June 29, 2004 |
Forbes Medi-Tech Inc. President & CEO on ROB TV |
| June 29, 2004 |
Forbes Medi-Tech Announces Increase in Revenue Guidance Based on Growth in Sterol Sales |
| June 03, 2004 |
Forbes Achieves Major Milestone Towards New Zealand & Australian Approval of Reducol(tm) |
| May 27, 2004 |
Forbes Medi-Tech Appoints Don Buxton as Chairman of the Board |
| May 17, 2004 |
Forbes Medi-Tech announces Financial Results for the Quarter ended March 31, 2004 |
| April 26, 2004 |
CIBC World Markets Audio Broadcast of Forbes Medi-Tech Inc. Presentation at the Annual Biotechnology & Specialty Pharmaceuticals Conference |
| April 20, 2004 |
Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2003 |
| April 19, 2004 |
Forbes Medi-Tech Announces Timing of Year End Financial Results and AGM |
| April 19, 2004 |
Forbes Medi-Tech Announces Additional European Phase II Trial Data for FM-VP4 |
| April 14, 2004 |
Forbes Medi-Tech Announces Second Milestone Completion for Reducol(tm) Sales in Europe |
| April 06, 2004 |
Forbes Medi-Tech to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference |
| April 05, 2004 |
Forbes Medi-Tech Announces European Phase II Trial Results for FM-VP4 |
| April 02, 2004 |
Forbes Medi-Tech Announces Timing of European Phase II Clinical Trial Results |
| March 26, 2004 |
Forbes Medi-Tech Signs Reducol(tm) Licensing and Distribution Agreement with Marco Hi-Tech |
| February 19, 2004 |
Forbes Medi-Tech Increases Depth of its Medical & Scientific Advisory Board with Appointment of Four Key Leaders in Cardiovascular Research |
| February 09, 2004 |
Forbes Medi-Tech Completes Regulatory Filing Pursuant to Previous Financing |
| February 03, 2004 |
Forbes Medi-Tech Completes Dosing for Phase II clinical trial on FM-VP4 |
| January 07, 2004 |
Forbes Medi-Tech Attracts Leading Cardiologist from Cleveland Clinic & Completes Equity Financing of US$10.75 Million |
| December 12, 2003 |
Forbes Achieves Major Milestone Towards European Approval of Reducol(tm) |
| December 09, 2003 |
Forbes Medi-Tech Expands Plant Capacity to 1,500 Metric Tonnes ~Demand for Sterols Supports Phyto-Source Expansion~ |
| December 03, 2003 |
Forbes Medi-Tech Files U.S. Registration Statement Pursuant to Previous Financing |
| November 25, 2003 |
Forbes Medi-Tech announces Financial Results for the Third Quarter ended September 30, 2003 |
| November 17, 2003 |
Forbes Medi-Tech Announces Timing of Third Quarter Financial Results |
| October 22, 2003 |
Forbes Medi-Tech Co-Sponsors CIHR Research Chair with Dr. Kishor Wasan |
| September 16, 2003 |
Forbes Medi-Tech Appoints New Member to Board of Directors |
| September 05, 2003 |
Forbes Medi-Tech Raises US$4.65 Million in Equity Financing |
| August 20, 2003 |
Forbes Medi-Tech Receives Approval for Nasdaq National Market Listing |
| August 19, 2003 |
Forbes Medi-Tech announces Financial Results for the Second Quarter ended June 30, 2003 - Second Quarter Revenues up 30%, Company Improves Operating Results |
| August 13, 2003 |
Forbes Medi-Tech Announces Closing of Phyto-Source Financing |
| August 12, 2003 |
Forbes Medi-Tech Announces Timing of Second Quarter Financial Results |
| July 18, 2003 |
Forbes Medi-Tech Signs International Reducol (tm) Sales and Licensing Agreement |
| July 15, 2003 |
Forbes Medi-Tech Maintains Nasdaq SmallCap Listing |
| July 02, 2003 |
Forbes Medi-Tech To Receive US$3 Million Partial Loan Repayment From Phyto-Source Manufacturing Joint Venture |
| June 27, 2003 |
Forbes Medi-Tech Announces US$2 Million Increase in Revenue Guidance Based on Growth in Sterol Sales |
| May 30, 2003 |
Forbes Medi-Tech AGM Update |
| May 05, 2003 |
Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2002 and First Quarter ended March 31, 2003 |
| May 01, 2003 |
Forbes Medi-Tech Announces Timing of Year End, First Quarter Financial Results and AGM |
| April 29, 2003 |
Forbes Medi-Tech Responds to Pan Pharmaceutical News |
| April 29, 2003 |
Forbes Medi-Tech Sells AD & ADD Technology for US$1.9 Million |
| April 16, 2003 |
Forbes Medi-Tech Announces NASDAQ Extension and Advisory Board Restructuring |
| March 04, 2003 |
Forbes Medi-Tech Announces Pharmavite Contract Extension |
| February 27, 2003 |
US FDA Issues Health Claim Letter to Forbes |
| January 27, 2003 |
Forbes Medi-Tech Completes Phase I Safety Study on FM-VP4 |
| January 20, 2003 |
Forbes Medi-Tech Initiates Dosing for Phase II clinical trials on FM-VP4 |
| January 15, 2003 |
Forbes Medi-Tech Begins Sterol Shipments Under Major Supply Agreement |
| December 20, 2002 |
Forbes Medi-Tech Announces Management Changes |
| December 11, 2002 |
Forbes Medi-Tech Fights Cholesterol with Chocolate |
| December 09, 2002 |
Special Warrant Investors Waive Requirement for Prospectus |
| December 04, 2002 |
Forbes Medi-Tech Provides Status of Pharmaceutical Development and Health Claim Status for Phytosterols |
| November 26, 2002 |
Forbes Medi-Tech Announces Third Quarter Results, Improves Financial Position and Outlook |
| November 20, 2002 |
Forbes Medi-Tech Announces Timing of Third Quarter Financial Results |
| November 14, 2002 |
Forbes Medi-Tech's Cholesterol-Lowering Oil Featured in Presentation at American Heart Association Conference |
| October 23, 2002 |
Forbes Medi-Tech Announces Corporate Restructuring and NASDAQ Extension |
| September 25, 2002 |
Forbes Medi-Tech Announces $975,000 in Financing |
| September 19, 2002 |
Forbes Medi-Tech Announces up to $40 Million in Sterols Sales Agreements |
| September 04, 2002 |
Forbes Medi-Tech Announces Non-Brokered Financing Results |
| August 29, 2002 |
Forbes Medi-Tech Announces Record Second Quarter Revenues |
| August 27, 2002 |
Forbes Medi-Tech Announces Timing of Second Quarter Financial Results |
| August 16, 2002 |
Forbes Medi-Tech Completes Sale of Amqui Plant |
| August 12, 2002 |
Forbes Medi-Tech Announces Private Placement Offerings |
| August 08, 2002 |
Forbes Medi-Tech Approved for Phase II Clinical Trials |
| July 25, 2002 |
Forbes Medi-Tech Approved for Nasdaq SmallCap Market |
| July 18, 2002 |
Forbes Medi-Tech Applies for NASDAQ SmallCap Market |
| July 10, 2002 |
Forbes Medi-Tech Signs International Supply Agreement with Pan Pharmaceuticals Ltd. |
| June 27, 2002 |
Forbes Provides Annual General Meeting Update |
| June 25, 2002 |
Forbes Medi-Tech Settles with Novartis Consumer Health SA for Rights to Reducol(tm) |
| June 17, 2002 |
Forbes Medi-Tech Extends Settlement Negotiations With Novartis Consumer Health SA |
| May 30, 2002 |
Forbes Medi-Tech Announces First Quarter Financial Results |
| May 29, 2002 |
Forbes Medi-Tech Announces Timing of First Quarter Financial Results |
| May 22, 2002 |
Forbes Medi-Tech to Hold Annual General Meeting on June 26, 2002 |
| May 09, 2002 |
Forbes Medi-Tech's Cholesterol-Lowering Cooking Oil Helps Fight Fat |
| April 30, 2002 |
Forbes Medi-Tech Announces Record Monthly Revenues |
| April 18, 2002 |
Forbes Medi-Tech Receives C$1.6 Million Offer to Purchase Amqui Plant |
| March 28, 2002 |
Forbes Medi-Tech Provides Update on Operations |
| March 18, 2002 |
Forbes Medi-Tech Declines to Buy Back Reducol(tm) Rights from Novartis |
| March 13, 2002 |
Forbes Medi-Tech Announces Board and Senior Management Changes |
| February 26, 2002 |
Forbes Medi-Tech Offers to Assist with Take Heart(tm) Line of Food Products |
| January 31, 2002 |
Forbes Medi-Tech Initiates Phase I Clinical Trial of Cholesterol-Lowering Pharmaceutical FM-VP4 Trial Results Expected in Mid- 2002 |
| January 15, 2002 |
Forbes Medi-Tech Completes Construction of Phytosterol Manufacturing Plant |
| December 27, 2001 |
Forbes Medi-Tech Reports Record Revenues for the First Quarter of Fiscal 2002 |
| December 18, 2001 |
Forbes Medi-Tech To Acquire Reducol(tm) Rights from Novartis Consumer Health |
| December 18, 2001 |
Forbes Medi-Tech Retains Fahnestock and Canaccord Europe As Financial Advisors |
| November 28, 2001 |
Forbes Medi-Tech Announces Record Fourth Quarter and Year-End Revenues for 2001 |
| October 31, 2001 |
Pharmavite Corporation Launches Cholest-Off(tm) in U.S. Containing Forbes Medi-Tech's Cholesterol Lowering Phytrol(tm) (Reducol(tm)) |
| October 09, 2001 |
Forbes Medi-Tech Calls For Regulatory Review Process In Canada To Incorporate Phytosterols Into Food Products |
| September 24, 2001 |
Forbes Medi-Tech Receives Approval to Initiate Phase I/II Clinical Trial of Cholesterol-Lowering Pharmaceutical FM-VP4 |
| August 13, 2001 |
Forbes Medi-Tech and the University of British Columbia Receive CIHR Research Grant to Study Cholesterol Lowering Sterol-Based Pharmaceuticals |
| July 31, 2001 |
Cholesterol Lowering Dietary Supplement Containing Forbes Medi-Tech's Phytrol(tm) (Reducol(tm)) Introduced by Twinlab Corporation |
| July 24, 2001 |
Cholesterol-Lowering Food Products Containing Forbes Medi-Tech's Phytrol(tm) (Reducol(tm)) Launched in U.S. |
| June 29, 2001 |
Forbes Medi-Tech Reports Third Quarter Results and Significant Reduction in Losses |
| June 11, 2001 |
New Regulations Affecting Phytosterol-based Food Products in Australia |
| June 05, 2001 |
Forbes Medi-Tech Receives Prestigious Scientific Award for Innovation in the Field of Food Ingredients |
| May 14, 2001 |
Forbes Medi-Tech FM-VP4 Pre-Clinical Study Results Presented to American Heart Association Conference |
| May 03, 2001 |
Forbes Reorganizes and Enhances Management Team - Company Appoints New President - |
| April 26, 2001 |
Forbes Medi-Tech Inc. announces further FM-VP4 pre-clinical study results |
| April 25, 2001 |
Forbes Medi-Tech Inc. Announces CardioRex(tm) Phase II Clinical Trial Results |
| April 02, 2001 |
Forbes Medi-Tech Reports Second Quarter Results for Fiscal 2001 including First Significant Sales of Phytrol(tm) |
| February 20, 2001 |
Pauls Limited Launches Cholesterol-Lowering Milk Containing Reducol(tm) In Australia |
| February 15, 2001 |
Forbes Winding Down Operations at its Amqui Plant |
| February 12, 2001 |
Forbes Appoints Chief Financial Officer |
| January 30, 2001 |
Forbes Provides Annual General Meeting Update |
| January 23, 2001 |
Forbes Enters into a US$20 Million Joint Venture to Build One of the World's Largest Sterol Manufacturing Facilities |
| January 08, 2001 |
Chief Financial Officer resigns from Forbes Medi-Tech |
| January 03, 2001 |
Forbes Medi-Tech Continues to Strengthen its Proprietary Position as a Global Leader in Sterol Technology |
| December 29, 2000 |
Forbes Medi-Tech Reports First Quarter 2001 Financial Results |
| December 20, 2000 |
Forbes Appoints Technology Advisory Board |
| December 18, 2000 |
Forbes Medi-Tech Inc. Reports Fourth Quarter and Year-end Results for the fiscal year ended July 31, 2000 |
| December 13, 2000 |
Forbes Announces the Appointment of Joe Dunne to the Board of Directors |
| December 07, 2000 |
Forbes Provides Corporate Update |
| November 29, 2000 |
Forbes Develops "Designer Oil" Which Lowers Cholesterol And May Prevent Weight Gain |
| November 21, 2000 |
Forbes Opens $3 Million Biotechnology Research Laboratories On University Of British Columbia Campus |
| November 09, 2000 |
Forbes Appoints Senior Pharmaceutical Executive to Board of Directors |
| October 31, 2000 |
Forbes reports additional exciting data on FM-VP4 - a novel cardiovascular pharmaceutical compound |
| October 19, 2000 |
PHYTROL(tm) BASED FOOD PRODUCTS LAUNCHED IN AUSTRALIA AND THE USA |
| August 29, 2000 |
Forbes Provides Corporate Update |
| August 14, 2000 |
Forbes Signs Manufacturing, Sales and Marketing Agreements for Pharmaceutical Steroid Products |
| July 14, 2000 |
Forbes Medi-Tech Completes CDN $27.75 Million Financing |
| July 11, 2000 |
Forbes Medi-Tech Appoints CFO, Senior Vice President |
| July 05, 2000 |
Forbes Medi-Tech Announces CDN $18.5 Million Bought Deal |
| June 30, 2000 |
Forbes Medi-Tech Announces Equity Offering |
| June 28, 2000 |
Forbes Medi-Tech Signs Supply Agreement with Cargill and Reports Third Quarter Results |
| June 19, 2000 |
Forbes Granted Patent on Microbial Conversion of Phytosterols to Steroid Drug Intermediates |
| June 14, 2000 |
New Pharmaceutical Compound Dramatically Reduced Atherosclerotic Lesions in Pre-Clinical Trails |
| May 25, 2000 |
Preliminary Study Results Indicate Exceptional Cholesterol Lowering Capability of New Pharmaceutical Compound |
| May 24, 2000 |
Exercise of Forbes Warrants Results in Gross Proceeds of $6.6 Million |
| May 04, 2000 |
Phytrol(tm) Receives FDA Clearance |
| April 25, 2000 |
Forbes Medi-Tech Announces Management Changes |
| April 25, 2000 |
Forbes Medi-Tech Obtains BC Technology Award |
| April 04, 2000 |
Forbes Medi-Tech Initiates US Phase II Trial for CardioRexTM |
| March 31, 2000 |
Second Quarter Report |
| March 14, 2000 |
Forbes Medi-Tech Inc. trades on the NASDAQ National Market |
| March 07, 2000 |
Forbes Medi-Tech Inc. Announces Nasdaq Listing Approval |
| February 03, 2000 |
Forbes Strengthens Business Development with Key Senior Management Addition |
| January 13, 2000 |
Forbes Provides Corporate Update |
